Rekah Pharmaceutical (Israel) Analysis
| REKA Stock | ILA 1,422 16.00 1.11% |
Rekah Pharmaceutical Industry is overvalued with Real Value of 1185.45 and Hype Value of 1422.0. The main objective of Rekah Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Rekah Pharmaceutical Industry is worth, separate from its market price. There are two main types of Rekah Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Rekah Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Rekah Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Rekah Pharmaceutical stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Rekah Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
Rekah |
Rekah Stock Analysis Notes
About 37.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.11. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rekah Pharmaceutical last dividend was issued on the 6th of April 2022. Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company was founded in 1941 and is based in Holon, Israel. REKAH PHARMA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 9 people. To find out more about Rekah Pharmaceutical Industry contact Mordechai Elgrabli at 972 3 558 1233 or learn more at https://www.rekah.co.il.Rekah Pharmaceutical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Rekah Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Rekah Pharmaceutical Industry or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Rekah Pharmaceutical had very high historical volatility over the last 90 days | |
| About 37.0% of the company outstanding shares are owned by corporate insiders |
Rekah Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 193.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rekah Pharmaceutical's market, we take the total number of its shares issued and multiply it by Rekah Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Rekah Profitablity
Rekah Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Rekah Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Rekah Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Rekah Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Rekah Pharmaceutical's profitability requires more research than a typical breakdown of Rekah Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Technical Drivers
As of the 27th of November, Rekah Pharmaceutical holds the Risk Adjusted Performance of (0.01), variance of 11.94, and Coefficient Of Variation of (3,616). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rekah Pharmaceutical, as well as the relationship between them.Rekah Pharmaceutical Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Rekah Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Rekah Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Rekah Pharmaceutical Outstanding Bonds
Rekah Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rekah Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rekah bonds can be classified according to their maturity, which is the date when Rekah Pharmaceutical Industry has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Rekah Pharmaceutical Predictive Daily Indicators
Rekah Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Rekah Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.045 | |||
| Daily Balance Of Power | (0.24) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1455.5 | |||
| Day Typical Price | 1444.33 | |||
| Market Facilitation Index | 67.0 | |||
| Price Action Indicator | (41.50) | |||
| Period Momentum Indicator | (16.00) | |||
| Relative Strength Index | 51.17 |
Rekah Pharmaceutical Forecast Models
Rekah Pharmaceutical's time-series forecasting models are one of many Rekah Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rekah Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Rekah Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Rekah Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rekah shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rekah Pharmaceutical. By using and applying Rekah Stock analysis, traders can create a robust methodology for identifying Rekah entry and exit points for their positions.
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company was founded in 1941 and is based in Holon, Israel. REKAH PHARMA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 9 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Rekah Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Complementary Tools for Rekah Stock analysis
When running Rekah Pharmaceutical's price analysis, check to measure Rekah Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rekah Pharmaceutical is operating at the current time. Most of Rekah Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Rekah Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rekah Pharmaceutical's price. Additionally, you may evaluate how the addition of Rekah Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |